Dosage and administration
One tablet daily or as directed by a physician.
One tablet daily or as directed by a physician.

Other Ingredients: Silicified Microcrystalline Cellulose, White color coating (Hypromellose, Titanium Dioxide, Polyethylene Glycol, Ethyl Cellulose, Talc, Polysorbate 80, Castor Oil, Polyvinyl Alcohol), Croscarmellose Sodium, Silicon Dioxide, Magnesium Stearate, Fumed Silica.
VEGETARIAN FRIENDLY
SUGAR- LACTOSE- GLUTEN- AND DYE-FREE
Corvite® Free is a multivitamin/mineral indicated for the distinctive nutritional requirements of persons being treated for vitamin deficiencies by a physician.
Corvite® Free should not be used by patients with a known hypersensitivity to any of the listed ingredients.
| WARNING: KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Biotin levels higher than the recommended daily allowance may cause interference with some laboratory tests, including cardiovascular diagnostic tests (e.g. troponin) and hormone tests, and may lead to incorrect test results. Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and dietary supplements that you take, including biotin.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
Corvite® Free tablets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels.
Corvite® Free is white oval shaped bisected tablet, embossed “VP030”.
One tablet daily or as directed by a physician.
Corvite® Free Multivitamin/Mineral is supplied in bottles of 100 tablets.
Product Code: 68025-030-10
Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and excessive heat. Dispense in a tight, light resistant container as defined by the USP with a child resistant closure.
For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-877-95-VERTI (1-877-958-3784) or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Customer Service: 1-866-600-4799 Rev. 07/2018
Distributed by:
Vertical Pharmaceuticals, LLC
Bridgewater, NJ 08807

68025-030-10
CORVITE® FREE
TABLETS
MULTIVITAMIN / MINERAL SUPPLEMENT
VEGETARIAN FRIENDLY
SUGAR, LACTOSE, GLUTEN & DYE FREE
100 Tablets
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-030-10 | EA - Each | 68025-030 | 34a46791-762b-4601-abc1-3eba8e7d351b | 1 | 2013-08-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-lipoic acid | ACTIVE INGREDIENT | 73Y7P0K73Y | 2 | |
| .alpha.-tocopherol succinate, d- | ACTIVE INGREDIENT | LU4B53JYVE | 2 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 2 | |
| biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 2 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| chromic chloride | ACTIVE INGREDIENT | KB1PCR9DMW | 2 | |
| copper gluconate | ACTIVE INGREDIENT | RV823G6G67 | 2 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| lutein | ACTIVE INGREDIENT | X72A60C9MT | 2 | |
| lycopene | ACTIVE INGREDIENT | SB0N2N0WV6 | 2 | |
| magnesium oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 2 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| pantothenic acid | ACTIVE INGREDIENT | 19F5HK2737 | 2 | |
| pyridoxine hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 2 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 2 | |
| selenomethionine | ACTIVE INGREDIENT | 964MRK2PEL | 2 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 2 | |
| ubidecarenone | ACTIVE INGREDIENT | EJ27X76M46 | 2 | |
| zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| .alpha.-lipoic acid | ACTIVE MOIETY | 73Y7P0K73Y | 2 | |
| .alpha.-tocopherol, d- | ACTIVE MOIETY | N9PR3490H9 | 2 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 2 | |
| biotin | ACTIVE MOIETY | 6SO6U10H04 | 2 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 2 | |
| chromic cation | ACTIVE MOIETY | X1N4508KF1 | 2 | |
| cupric cation | ACTIVE MOIETY | 8CBV67279L | 2 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| lutein | ACTIVE MOIETY | X72A60C9MT | 2 | |
| lycopene | ACTIVE MOIETY | SB0N2N0WV6 | 2 | |
| magnesium cation | ACTIVE MOIETY | T6V3LHY838 | 2 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 2 | |
| pantothenic acid | ACTIVE MOIETY | 19F5HK2737 | 2 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 2 | |
| selenium | ACTIVE MOIETY | H6241UJ22B | 2 | |
| thiamine ion | ACTIVE MOIETY | 4ABT0J945J | 2 | |
| ubidecarenone | ACTIVE MOIETY | EJ27X76M46 | 2 | |
| zinc cation | ACTIVE MOIETY | 13S1S8SF37 | 2 | |
| castor oil | INACTIVE INGREDIENT | D5340Y2I9G | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 2 | |
| ethylcelluloses | INACTIVE INGREDIENT | 7Z8S9VYZ4B | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 2 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 2 | |
| polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | 2 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68025-030 | 68025-030-10 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| ethylcelluloses | ETHYLCELLULOSE | 7Z8S9VYZ4B | TABLET, COATED / ORAL | 20 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE / ORAL | 257 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| ethylcelluloses | ETHYLCELLULOSE | 7Z8S9VYZ4B | POWDER, FOR SUSPENSION / ORAL | NA | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CREAM / TOPICAL | 20 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SOLUTION/ DROPS / OPHTHALMIC | 1.4 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | PASTE / ORAL | 28 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 8 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 7 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / OPHTHALMIC | 1.4 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| polyvinyl alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION/ DROPS / OPHTHALMIC | 1.4 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic acid | ASCORBIC ACID | Zydus Pharmaceuticals USA Inc. | f0b683f8-189b-4a3f-9ffe-f91df6d798b6 | 2026-09-03 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic acid | ASCORBIC ACID | Zydus Lifesciences Limited | d2d29ffd-5483-45bb-9d1b-da7af23b3720 | 2026-09-03 | ASCORBIC ACID | |
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.